These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 18634926)
41. Comparison of mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars: 42-month follow-up and survival analysis. Mettlach SE; Zealand CM; Botero TM; Boynton JR; Majewski RF; Hu JC Pediatr Dent; 2013; 35(3):E87-94. PubMed ID: 23756301 [TBL] [Abstract][Full Text] [Related]
42. Clinical and radiographic success of mineral trioxide aggregate compared with formocresol as a pulpotomy treatment in primary molars: a systematic review and meta-analysis. Marghalani AA; Omar S; Chen JW J Am Dent Assoc; 2014 Jul; 145(7):714-21. PubMed ID: 24982277 [TBL] [Abstract][Full Text] [Related]
44. Evaluation of three pulpotomy medicaments in primary teeth. Markovic D; Zivojinovic V; Vucetic M Eur J Paediatr Dent; 2005 Sep; 6(3):133-8. PubMed ID: 16216093 [TBL] [Abstract][Full Text] [Related]
45. Comparison of bioactive glass, mineral trioxide aggregate, ferric sulfate, and formocresol as pulpotomy agents in rat molar. Salako N; Joseph B; Ritwik P; Salonen J; John P; Junaid TA Dent Traumatol; 2003 Dec; 19(6):314-20. PubMed ID: 15022999 [TBL] [Abstract][Full Text] [Related]
46. Clinical and radiographic comparison of platelet-rich fibrin and mineral trioxide aggregate as pulpotomy agents in primary molars. Patidar S; Kalra N; Khatri A; Tyagi R J Indian Soc Pedod Prev Dent; 2017; 35(4):367-373. PubMed ID: 28914251 [TBL] [Abstract][Full Text] [Related]
47. Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2-year follow-up. Fernández CC; Martínez SS; Jimeno FG; Lorente Rodríguez AI; Mercadé M Int J Paediatr Dent; 2013 Nov; 23(6):400-7. PubMed ID: 23171351 [TBL] [Abstract][Full Text] [Related]
48. The Clinical and Radiographic Success of Primary Molar Pulpotomy Using Biodentine™ and Mineral Trioxide Aggregate: A 24-Month Randomized Clinical Trial. Bani M; Aktaş N; Çınar Ç; Odabaş ME Pediatr Dent; 2017 Jul; 39(4):284-288. PubMed ID: 29122067 [TBL] [Abstract][Full Text] [Related]
49. Pulpotomy in caries-exposed immature permanent molars using calcium-enriched mixture cement or mineral trioxide aggregate: a randomized clinical trial. Nosrat A; Seifi A; Asgary S Int J Paediatr Dent; 2013 Jan; 23(1):56-63. PubMed ID: 22309243 [TBL] [Abstract][Full Text] [Related]
50. Mineral trioxide aggregate as a pulpotomy agent in primary molars: an in vivo study. Naik S; Hegde AH J Indian Soc Pedod Prev Dent; 2005 Mar; 23(1):13-6. PubMed ID: 15858300 [TBL] [Abstract][Full Text] [Related]
51. Dentin bridge formation after mineral trioxide aggregate (MTA) pulpotomies in primary teeth. Maroto M; Barbería E; Planells P; García Godoy F Am J Dent; 2005 Jun; 18(3):151-4. PubMed ID: 16158803 [TBL] [Abstract][Full Text] [Related]
52. A comparative evaluation of clinical and radiographic success rate of pulpotomy in primary molars using antioxidant mix and mineral trioxide aggregate: An in vivo 1-year follow-up study. Kathal S; Gupta S; Bhayya DP; Rao A; Roy AP; Sabhlok A J Indian Soc Pedod Prev Dent; 2017; 35(4):327-331. PubMed ID: 28914245 [TBL] [Abstract][Full Text] [Related]
53. Dentin bridge formation after white mineral trioxide aggregate (white MTA) pulpotomies in primary molars. Maroto M; Barbería E; Vera V; García-Godoy F Am J Dent; 2006 Apr; 19(2):75-9. PubMed ID: 16764128 [TBL] [Abstract][Full Text] [Related]
54. The evaluation of MTA and Biodentine as a pulpotomy materials for carious exposures in primary teeth. Çelik BN; Mutluay MS; Arıkan V; Sarı Ş Clin Oral Investig; 2019 Feb; 23(2):661-666. PubMed ID: 29744721 [TBL] [Abstract][Full Text] [Related]
55. Comparison of Ferric Sulfate Combined Mineral Trioxide Aggregate Pulpotomy and Zinc Oxide Eugenol Pulpectomy of Primary Maxillary Incisors: An 18-month Randomized, Controlled Trial. Nguyen TD; Judd PL; Barrett EJ; Sidhu N; Casas MJ Pediatr Dent; 2017 Jan; 39(1):34-38. PubMed ID: 28292339 [TBL] [Abstract][Full Text] [Related]
56. Evaluation and comparison of white mineral trioxide aggregate and formocresol medicaments in primary tooth pulpotomy: clinical and radiographic study. Jayam C; Mitra M; Mishra J; Bhattacharya B; Jana B J Indian Soc Pedod Prev Dent; 2014; 32(1):13-8. PubMed ID: 24531596 [TBL] [Abstract][Full Text] [Related]
57. Comparative efficacy of medicaments or techniques for pulpotomy of primary molars: a network meta-analysis. Guo J; Zhang N; Cheng Y Clin Oral Investig; 2023 Jan; 27(1):91-104. PubMed ID: 36580161 [TBL] [Abstract][Full Text] [Related]
58. Clinical and radiographic evaluation of white MTA versus formocresol pulpotomy: A 48-month follow-up study. Biedma Perea M; Solano Mendoza B; Garcia-Godoy F; Mendoza Mendoza A; Iglesias-Linares A Am J Dent; 2017 Jun; 30(3):131-136. PubMed ID: 29178757 [TBL] [Abstract][Full Text] [Related]
59. Biodentine used as a pulp-capping agent in primary pig teeth. Shayegan A; Jurysta C; Atash R; Petein M; Abbeele AV Pediatr Dent; 2012; 34(7):e202-8. PubMed ID: 23265156 [TBL] [Abstract][Full Text] [Related]
60. Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth. Aeinehchi M; Dadvand S; Fayazi S; Bayat-Movahed S Int Endod J; 2007 Apr; 40(4):261-7. PubMed ID: 17309744 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]